Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca gambles on a $40M round for diabetes/cardio biotech PhaseBio
AstraZeneca gambles on a $40M round for diabetes/cardio biotech PhaseBio
AstraZeneca gambles on a $40M round for diabetes/cardio biotech PhaseBio
Submitted by
admin
on March 12, 2015 - 10:44am
Source:
Fierce Biotech
News Tags:
AstraZeneca
diabetes
PhaseBio
Headline:
AstraZeneca gambles on a $40M round for diabetes/cardio biotech PhaseBio
Do Not Allow Advertisers to Use My Personal information
